Gujarat Terce Laboratories Limited (BOM:524314)

India flag India · Delayed Price · Currency is INR
38.53
+0.22 (0.57%)
At close: Mar 10, 2026
-44.97%
Market Cap 300.20M
Revenue (ttm) 483.98M
Net Income (ttm) -12.81M
Shares Out 7.79M
EPS (ttm) -1.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,223
Average Volume 3,422
Open 41.63
Previous Close 38.31
Day's Range 38.00 - 41.63
52-Week Range 37.20 - 73.95
Beta 0.70
RSI 42.37
Earnings Date May 26, 2026

About BOM:524314

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporate... [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 244
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524314
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.